Correlation Between VistaGen Therapeutics and Sage Therapeutic

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both VistaGen Therapeutics and Sage Therapeutic at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining VistaGen Therapeutics and Sage Therapeutic into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between VistaGen Therapeutics and Sage Therapeutic, you can compare the effects of market volatilities on VistaGen Therapeutics and Sage Therapeutic and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in VistaGen Therapeutics with a short position of Sage Therapeutic. Check out your portfolio center. Please also check ongoing floating volatility patterns of VistaGen Therapeutics and Sage Therapeutic.

Diversification Opportunities for VistaGen Therapeutics and Sage Therapeutic

0.75
  Correlation Coefficient

Poor diversification

The 3 months correlation between VistaGen and Sage is 0.75. Overlapping area represents the amount of risk that can be diversified away by holding VistaGen Therapeutics and Sage Therapeutic in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sage Therapeutic and VistaGen Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on VistaGen Therapeutics are associated (or correlated) with Sage Therapeutic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sage Therapeutic has no effect on the direction of VistaGen Therapeutics i.e., VistaGen Therapeutics and Sage Therapeutic go up and down completely randomly.

Pair Corralation between VistaGen Therapeutics and Sage Therapeutic

Given the investment horizon of 90 days VistaGen Therapeutics is expected to generate 6.82 times more return on investment than Sage Therapeutic. However, VistaGen Therapeutics is 6.82 times more volatile than Sage Therapeutic. It trades about 0.04 of its potential returns per unit of risk. Sage Therapeutic is currently generating about -0.06 per unit of risk. If you would invest  360.00  in VistaGen Therapeutics on September 4, 2024 and sell it today you would lose (77.00) from holding VistaGen Therapeutics or give up 21.39% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

VistaGen Therapeutics  vs.  Sage Therapeutic

 Performance 
       Timeline  
VistaGen Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days VistaGen Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest conflicting performance, the Stock's technical and fundamental indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.
Sage Therapeutic 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sage Therapeutic has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

VistaGen Therapeutics and Sage Therapeutic Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with VistaGen Therapeutics and Sage Therapeutic

The main advantage of trading using opposite VistaGen Therapeutics and Sage Therapeutic positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if VistaGen Therapeutics position performs unexpectedly, Sage Therapeutic can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sage Therapeutic will offset losses from the drop in Sage Therapeutic's long position.
The idea behind VistaGen Therapeutics and Sage Therapeutic pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Complementary Tools

Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Bonds Directory
Find actively traded corporate debentures issued by US companies